Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk suing Hims & Hers

Digest more
 · 4d
Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context, published pricing disclosures, telehealth eligibility considerations,

Continue reading

 · 19h · on MSN
Novo Nordisk suing Hims & Hers over 'copycat' weight loss drug
 · 2d
Hims & Hers Drops Plan for Knockoff of Novo Nordisk's New Wegovy Weight Loss Pill
4don MSN

Hims shares plunge after FDA threatens action on 'illegal copycat drugs'

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action against companies that mass-market "illegal copycat drugs" by claiming they are ...
2don MSN

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...
24/7 Wall St.
2d

FDA and HHS Hammer Hims & Hers In Compounded Drug Crackdown

Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies ...
2d

Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
  • Privacy
  • Terms